A detailed history of Atomi Financial Group, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 1,832 shares of CRL stock, worth $368,781. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,832
Previous 1,914 4.28%
Holding current value
$368,781
Previous $395 Million 8.76%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$187.96 - $245.29 $15,412 - $20,113
-82 Reduced 4.28%
1,832 $361 Million
Q2 2024

Jul 26, 2024

SELL
$206.39 - $268.73 $16,923 - $22,035
-82 Reduced 4.11%
1,914 $395 Million
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $406,225 - $545,766
1,996 New
1,996 $541 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Atomi Financial Group, Inc. Portfolio

Follow Atomi Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atomi Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atomi Financial Group, Inc. with notifications on news.